Lp(a) for Professionals


Lp(a) is a genetic independent risk factor for cardiovascular disease.

An estimated 20% to 30% of people worldwide have high levels of plasma lipoprotein(a).

It is important for clinicians to incorporate comprehensive guidelines for diagnosing, treating, and managing elevated Lp(a) into patient evaluation and risk assessment.

White and red blood cells in 3D Illustration

eModule

Identify & Manage Lp(a)

In this eModule, healthcare professionals can explore the role of lipoprotein (a) or Lp(a) as an emerging atherosclerotic cardiovascular disease (ASCVD) risk factor. Lp(a) is an inherited lipid disorder that is underdiagnosed and underappreciated as a driver of ASCVD.

Toolkits

Healthcare Professional Toolkit Cover

Lp(a): A Toolkit for Healthcare Professionals

Elevated Lp(a) is associated with heightened risk for myocardial infarction, peripheral artery disease, stroke, and calcific aortic valve disease. Learn more in this toolkit for healthcare professionals.

Lp(a) and Peripheral Artery Disease: Emerging Diagnosis and Management

PAD patients should be screened for elevated Lp(a) if they have a family history of atherosclerotic CVD or recurrence of major adverse limb events despite optimal medical therapy. Learn more about Lp(a) and PAD in this toolkit for health care professionals.
LPa PAD Toolkit Cover Page

Videos On Demand

Lipoprotein(a): Add Peripheral Artery Disease to the List of Targets

This video on demand emphasizes the impact elevated Lp(a) has on patients with PAD and highlights the importance of testing Lp(a). Leading experts will address comprehensive clinical recommendations for managing patients with elevated Lp(a) and PAD.

Lp(a): An Atherosclerotic Cardiovascular Disease (ASCVD)

Risk Factor That Can No Longer Be Ignored

This webinar will provide education for health care professionals on genetics and the importance of measuring Lp(a) levels. Leading experts will address comprehensive clinical recommendations to incorporate patient-centered care for diagnosing, treating, and managing patients with elevated Lp(a).

Approaches to Identification

Approaches to identification and management of patients with increased LDL-C and Lp(a)
Professional Education Hub

Lp(a) Patient Education Resources

Talking to patients about their Lp(a) levels can help reduce their risk of heart disease. Check out these free downloadable Patient Education Resources to use in conversation with your patients:
Patient and doctor talking

Guidelines-on-the-Go

Photo of female healthcare professional looking at a smart phone. Banner says, "Guidelines On The Go, AHA science at your fingertips"

The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.